Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP495431.RA0DiAwj1Ixn9ioqLckkiysioEyGyaaeH5kkI7wA-CMXA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP495431.RA0DiAwj1Ixn9ioqLckkiysioEyGyaaeH5kkI7wA-CMXA130_assertion type Assertion NP495431.RA0DiAwj1Ixn9ioqLckkiysioEyGyaaeH5kkI7wA-CMXA130_head.
- NP495431.RA0DiAwj1Ixn9ioqLckkiysioEyGyaaeH5kkI7wA-CMXA130_assertion description "[It also indicates that AKT may therefore be a novel molecular target for therapies or chemosensitivity tests that improve the outcomes of gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495431.RA0DiAwj1Ixn9ioqLckkiysioEyGyaaeH5kkI7wA-CMXA130_provenance.
- NP495431.RA0DiAwj1Ixn9ioqLckkiysioEyGyaaeH5kkI7wA-CMXA130_assertion evidence source_evidence_literature NP495431.RA0DiAwj1Ixn9ioqLckkiysioEyGyaaeH5kkI7wA-CMXA130_provenance.
- NP495431.RA0DiAwj1Ixn9ioqLckkiysioEyGyaaeH5kkI7wA-CMXA130_assertion SIO_000772 15900596 NP495431.RA0DiAwj1Ixn9ioqLckkiysioEyGyaaeH5kkI7wA-CMXA130_provenance.
- NP495431.RA0DiAwj1Ixn9ioqLckkiysioEyGyaaeH5kkI7wA-CMXA130_assertion wasDerivedFrom befree-2016 NP495431.RA0DiAwj1Ixn9ioqLckkiysioEyGyaaeH5kkI7wA-CMXA130_provenance.
- NP495431.RA0DiAwj1Ixn9ioqLckkiysioEyGyaaeH5kkI7wA-CMXA130_assertion wasGeneratedBy ECO_0000203 NP495431.RA0DiAwj1Ixn9ioqLckkiysioEyGyaaeH5kkI7wA-CMXA130_provenance.